Showing results (121-130 of 288) with videos related to
Sort By:
Pageof 29
Experimental Hematology|August 6, 2010
KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406)Barbara Peter, Emir Hadzijusufovic, Katharina Blatt, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2024
Repeated CXCR4 Blockade by Plerixafor Attenuates Transplant Vasculopathy in Murine Aortic AllograftsFrank Theil, Annika Kuckhahn, André Hörning, et al.Wiener Klinische Wochenschrift|May 26, 2025
Acute liver failure in patients admitted to the intensive care unit-a Viennese retrospective single-center analysisPatrick Haselwanter, Seanna Fairfield, Marlene Riedl-Wewalka, et al.Journal of Vascular Surgery|March 6, 2003
Regulation of tissue factor expression in smooth muscle cells with nitric oxideMelina R Kibbe, Christopher Johnnides, Susan Gleixner, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 29, 2014
Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allograftsChristian Heim, Sebastian Eckl, Raimund Preidl, et al.Annals of Hematology|September 5, 2025
Bone marrow mastocytosis associated with primary cutaneous follicle center lymphoma: an unusual case reportMax Vincent John, Ingrid Simonitsch-Klupp, Johannes Griss, et al.International Journal of Molecular Sciences|September 1, 2019
Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CMLPeter Valent, Irina Sadovnik, Gregor Eisenwort, et al.Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 1, 2012
Reduction of transplant arteriosclerosis after treatment with mycophenolate mofetil and ganciclovir in a mouse aortic allograft modelJulia Hoffmann, Martin Böhm, Silke Abele-Ohl, et al.Transplant Immunology|September 4, 2016
Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse modelChristian Heim, Benjamin Motsch, Sabina Jalilova, et al.Blood|May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationE Holler, H J Kolb, E Hiller, et al.Pageof 29